TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 23 | 4 | −19 |
| Shares | 733.8K | 43.6K | −690.2K (−94.1%) |
| Value | $1.48M | $196 | −$1.47M (−100.0%) |
New holders (1)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 3,010 | $196 | 0.00% |
Sold out (20)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Carlson Capital L P | 293,460 | $589.9K |
| Armistice Capital, LLC | 228,000 | $458.3K |
| Westside Investment Management, Inc. | 75,264 | $151.3K |
| Geode Capital Management, LLC | 27,999 | $56.3K |
| Renaissance Technologies LLC | 20,497 | $41.2K |
| Citadel Advisors LLC | 13,579 | $27.3K |
| Vanguard Group Inc | 12,136 | $24.4K |
| Nwam LLC | 10,240 | $20.6K |
| BlackRock, Inc. | 7,186 | $14.4K |
| Tower Research Capital LLC (TRC) | 1,948 | $3.92K |
| Nordwand Advisors, LLC | 1,000 | $2.01K |
| University of Texas/Texas Am Investment Managment Co | 882 | $1.77K |
| UBS Group AG | 675 | $1.36K |
| Raleigh Capital Management Inc. | 91 | $183 |
| Wells Fargo & Company | 61 | $123 |
| HM Payson & Co | 60 | $121 |
| Advisor Group Holdings, Inc. | 40 | $80 |
| Morgan Stanley | 32 | $64 |
| Bank of America Corp | 28 | $56 |
| Danske Bank A/S | 1 | $2 |